NCT04960722View on ClinicalTrials.gov

OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 11, 2022

Primary Completion Date

September 24, 2024

Study Completion Date

February 25, 2025

Conditions
Tibia Fracture
Interventions
DEVICE

OIF/β-TCP

bone graft implantation

Trial Locations (1)

Unknown

BioGend Therapeutics, Taipei

Sponsors
All Listed Sponsors
lead

BioGend Therapeutics Co.Ltd

INDUSTRY